AC IMMUNE S.A.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 34221
 
  
 
C07K PEPTIDES 16120
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0349,618 DISACCHARIDE SYNTHETIC LIPID COMPOUNDS AND USES THEREOFJun 07, 16Dec 07, 17[C07H, A61K]
2017/0002,005 Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like ProteinsJan 21, 15Jan 05, 17[A61K, C07D]
2014/0314,837 Vaccine TherapySep 21, 12Oct 23, 14[A61K, C07K]
2010/0285,108 Method for therapeutic useMar 18, 10Nov 11, 10[A61K, A61P]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9701660 2,6-diaminopyridine compounds suitable for treating diseases associated with amyloid or amyloid-like proteins or for treating or preventing ocular diseases or conditions associated with a pathological abnormality/change in the tissue of the visual systemSep 30, 14Jul 11, 17[A61K, C07D, G01N]
9687447 Method for preparing liposome-based constructsOct 26, 11Jun 27, 17[A61K, G01N, C07K]
9657091 Humanized tau antibodyMar 15, 13May 23, 17[G01N, C07K]
9598485 Anti-tau antibodies and methods of useMar 12, 14Mar 21, 17[A61K, C07K]
9585956 Polynucleotides encoding anti-amyloid beta monoclonal antibodiesSep 22, 15Mar 07, 17[C07H, A61K, G01N, C07K]
9540434 Phosphospecific antibodies recognising tauOct 05, 12Jan 10, 17[A61K, C12P, G01N, C07K]
9518078 Disaccharide synthetic lipid compounds and uses thereofApr 12, 13Dec 13, 16[C07H, A61K]
9403902 Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibodyOct 03, 08Aug 02, 16[A61K, C07K]
9304138 Pharmaceutical compositionOct 07, 11Apr 05, 16[A61K, G01N, C07K]
9289488 Vaccine engineeringAug 12, 11Mar 22, 16[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0272,699 HUMANIZED ANTIBODYAbandonedOct 28, 15Sep 22, 16[G01N, C07K]
2016/0244,514 Humanized AntibodyAbandonedDec 22, 15Aug 25, 16[A61K, C07K]
2016/0168,234 HUMANIZED ANTIBODY IGG1AbandonedJul 20, 15Jun 16, 16[G01N, C07K]
2013/0164,278 HUMANIZED ANTIBODYAbandonedAug 07, 12Jun 27, 13[C07K]
2012/0288,896 NUCLEIC ACID MOLECULES ENCODING ANTI-AMYLOID-BETA ANTIBODIESAbandonedJul 25, 12Nov 15, 12[C12P, C12N]
2012/0244,165 METHODS OF TREATING AMYLOIDOSIS COMPRISING THE USE OF ANTI-AMYLOID BETA ANTIBODIESAbandonedMay 01, 12Sep 27, 12[A61K, A61P]
2011/0256,064 Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like ProteinsAbandonedApr 15, 11Oct 20, 11[A61K, C07D, G01N, A61P]
2011/0070,613 Monoclonal AntibodyAbandonedFeb 05, 10Mar 24, 11[C07H, C12P, C12N]
2010/0297,012 HUMANIZED ANTIBODYAbandonedOct 03, 08Nov 25, 10[A61K, G01N, A61P, C07K]
2010/0297,013 HUMANIZED ANTIBODYAbandonedOct 03, 08Nov 25, 10[A61K, G01N, A61P, C07K]
2010/0297,132 Monoclonal antibodyAbandonedOct 23, 09Nov 25, 10[A61K, A61P]
2010/0247,688 PIRENZEPINE AND DERIVATIVES THEREOF AS ANTI-AMYLOID AGENTSAbandonedJul 02, 08Sep 30, 10[A61K, C07D, A61P]
2010/0183,513 N-(METHYL) -1H-PYRAZOL-3-AMINE, N-(METHYL)-PYRIDIN-2-AMINE AND N-(METHYL)-THIAZOL-2-AMINE DERIVATIVES FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINS, LIKE E.G. ALZHEIMER'SAbandonedNov 23, 07Jul 22, 10[A61K, C07D, G01N, A61P]
2010/0144,793 NOVEL COMPOUNDS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID OR AMYLOID-LIKE PROTEINSAbandonedNov 23, 07Jun 10, 10[A61K, C07D, G01N, A61P]
2009/0155,249 HUMANIZED ANTIBODY IGG1AbandonedJun 12, 08Jun 18, 09[A61K, C12N, G01N, C07K]
2008/0026,995 THERAPEUTIC VACCINE TARGETED AGAINST P-GLYCOPROTEIN 170 FOR INHIBITING MULTIDRUG RESISTANCE IN THE TREATMENT OF CANCERSAbandonedOct 18, 06Jan 31, 08[A61K, C12P, C12N, G01N, A61P, C07K]
2007/0281,881 Methods And Compositions Comprising Non-Peptide Small Molecules That Solubilize Beta Amyloid Peptide FiberAbandonedFeb 18, 05Dec 06, 07[A61K, C40B]
2006/0233,758 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersAbandonedNov 16, 05Oct 19, 06[A61K, C12N, G01N, C07K]
2005/0255,561 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersAbandonedFeb 16, 05Nov 17, 05[C07H, C12P, C07K]
2005/0244,419 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancersAbandonedJan 21, 05Nov 03, 05[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.